Member Info for inanaco

sentiment ? ........... we are Investors ..traders etc ... the only point of these BB's .. is to pull out and discuss potential issues or value added research ...

nobody should be even trying to influence Sentiment ... worse reason i have heard ..

" yes I bought into Scancell because Moljen made me happy"

(shares) subject to getting them all .......... opps !

I post on the science because it has a direct bearing of why i am holding 985,000 shares .......

i always welcomed the negatives on the science because it forced me to learn .......... now the negatives are so few that they only fall on "Risk Factor" which the majority cannot quantify ... ie it becomes a "personal risk factor"

in other words i did what i needed to do to learn .... i had posters desperate to find fault ... but they failed to develop there argument unlike myself and the way i approached the subject.

I do not want to waste anymore time on Drivel ........... I dont need to !! ISA full .. got enough shares

1/ Science is Brilliant
2/ Scancell is funded for two years
3/ all obstacles overcome apart from a Pandemic

the Ip is enormous compared to when we first invested for me that was 8p in 2012 (only based on SCIB1)

so you could argue the dilution of the number of shares and SP over that time add up to the increase in the value of the IP .
its as if the R and D did not happen ...

think of it like that ...

and Ludicrously cheap is in play

I am Glad Bermuda is Back ........... but its a level playing field ... so to level it up do you want me to pick sides ?

moljen plus bermuda ...... v Gf Plus myself ..

lets all play tag team posting ........... that really confuses anybody trying to follow the bb ...

even the subject of Dilution as explained by the bigger Cake principle got blown up out of all proportion because of "flawed maths" .. folks not understanding a Nulled equation .. even Now Ruck is still bleating about it .. even thou he posted on here he understood our point of view ...

its this relentless drivel that messes up the BB ...

I thought the discussion between you and Gf ... covered all bases .. why do we need another "open discussion" ... anyway good to see "pat buddy on the back" is in fashion again ..

maybe you should go back a bit (only a few weeks) and correct Moljens posts on T cell's repairing Virus infected cells ..

just a thought ..

i will also remind folks of this post

by the way KonarA24 Jul 2020 08:33
not jumping on anyone now ........
tell you why .. all the negatives about the BOD have been displaced by this RNS .. indeed the fact that Diggles has joined in again tells us that a non exec Board Member is still Keen on Scancell, and he also had the privilege of Due diligence prior to investing both times .

all major hurdles have been over come and the most significant is the up scaling process of manufacture of the Modi1 .. giving Scancell huge experience going forward considering many more vaccines will spin off from this technology ..

ok we still have a pandemic on our hands ........ however retail sales are back ... so the economic fall out on certain sectors maybe severe .. but lets hope that is only a shift rather than a disappearance

I am sure over the next 12 months the Government is going to free up planning restrictions,open Free ports ... and you will see an economy develop probably similar to Singapore over the coming years, its actually a very exciting time if you are entrepreneurial

Scancell is still in my opinion at the cutting edge of Immunotherapy and for the first time with the majority of the pipeline approaching the clinic probably in the most explosive position for the true value to be seen ...

the next 12 months is all about the science now ...........

from that data we get the deals ........ and the Golden Rule ... is Not about Big Names like Roche

its about "binding " and "Efficacy"

now i cannot add anymore on the science ... and the BOD are fully funded ..

sit back enjoy the Cricket

yes ... and better still

this fund raising brings in secondary buyers ... many investors track the funds to see who is buying what, and invest accordingly maybe not quite at the same price, but then they are not subject to management fees of those funds.

C7 i am well aware of that .. and fully understand GF's point ... i did not get involved .. however Moljen tried to include me in his High Horse rambling ... requiring my usual satirical response.

i have no idea who your talking about chap .. what is interesting i still have all the emails going back to 2012 and i have never deleted my phone history ...

I am sure Bermuda does not need Moljens support .......... or interference ..

and you are doing exactly the same ......... "presumption of what others are thinking"

why don't you just trade from the ISA account ? i appreciate you will not exceed the £10k capital gains tax threshold with Scancell trading in this range ... however .. you are protected in the event of a deal ..

Moljen ......... when you are ready to get off your high horse.. i suggest you call the fire brigade as no ladder for sale at Screwfix will reach

barclays has arrived ...

https://endpts.com/could-a-patent-ruling-threaten-modernas-covid-19-vaccine/

For years, Moderna has been battling a tiny Pennsylvania biotech over patents for a technology required to deliver its mRNA drugs and vaccines. Yesterday, a ruling came down at what might be the most inopportune time for Moderna, potentially delaying their Covid-19 vaccine or cutting into the potential profits that quintupled their stock in less than 5 months.

The US Patent and Trademark Office ruled that Arbutus Biopharma’s patents on that delivery method, known as lipid nanoparticles or LNPs, were not invalid, as Moderna had claimed.

The decision means that Arbutus could potentially stake a claim to the Covid-19 vaccine Moderna is planning to put into Phase III next week. They could do so either by filing an injunction to halt development or commercialization of the vaccine altogether — a potentially risky PR move amid a generational pandemic. Or by staking a claim for royalties — a move that, with a relatively low-margin product like vaccines, could chip at Moderna’s expected profits.

my Barclays account nothing ..... as yet

new thread

for Platforms ...

not jumping on anyone now ........
tell you why .. all the negatives about the BOD have been displaced by this RNS .. indeed the fact that Diggles has joined in again tells us that a non exec Board Member is still Keen on Scancell, and he also had the privilege of Due diligence prior to investing both times .

all major hurdles have been over come and the most significant is the up scaling process of manufacture of the Modi1 .. giving Scancell huge experience going forward considering many more vaccines will spin off from this technology ..

ok we still have a pandemic on our hands ........ however retail sales are back ... so the economic fall out on certain sectors maybe severe .. but lets hope that is only a shift rather than a disappearance

I am sure over the next 12 months the Government is going to free up planning restrictions,open Free ports ... and you will see an economy develop probably similar to Singapore over the coming years, its actually a very exciting time if you are entrepreneurial

Scancell is still in my opinion at the cutting edge of Immunotherapy and for the first time with the majority of the pipeline approaching the clinic probably in the most explosive position for the true value to be seen ...

the next 12 months is all about the science now ...........

from that data we get the deals ........ and the Golden Rule ... is Not about Big Names like Roche

its about "binding " and "Efficacy"

now i cannot add anymore on the science ... and the BOD are fully funded ..

sit back enjoy the Cricket

stage payments ......... so many variables including share options with the other company .. like Ichor did

Konar A ... the big money is taking a drug through the trial process ............ the Highly skilled part is developing the drug ready for the Clinic ... This is clearly scancells area of excellence .. again look at the successful format of arm holdings .. Skin in the game is getting partners excited enough to back it ... that confidence increases the value of the license .. and means the risk is spread between both parties each bringing a certain skill set to the game so that its clinic ready ...

the more information and data you have the easy it is to extract true value

yes but they need us now with the Chinese ...